(19)
(11) EP 1 801 218 A3

(12) EUROPEAN PATENT APPLICATION

(88) Date of publication A3:
10.10.2007 Bulletin 2007/41

(43) Date of publication A2:
27.06.2007 Bulletin 2007/26

(21) Application number: 07000680.4

(22) Date of filing: 27.07.1999
(51) International Patent Classification (IPC): 
C12N 15/31(2006.01)
C07K 16/12(2006.01)
A61K 39/09(2006.01)
G01N 33/68(2006.01)
C07K 14/315(2006.01)
A61K 31/70(2006.01)
G01N 33/53(2006.01)
C12Q 1/68(2006.01)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 27.07.1998 GB 9816336
19.03.1999 US 125329 P

(62) Application number of the earlier application in accordance with Art. 76 EPC:
05019268.1 / 1624064
99934990.5 / 1144640

(71) Applicant: Sanofi Pasteur Limited
Toronto, Ontario M2R 3T4 (CA)

(72) Inventors:
  • Le Page, Richard William Falla
    Cambridge CB2 1QP (GB)
  • Wells, Jeremy Mark
    6700 AH Wageningen (NL)
  • Hannify, Sean Bosco
    Cambridge CB2 1QP (GB)
  • Hansbro, Philip Michael, CBVT Dis. Immun. Microbio
    Newcastle, NSW 2300 (AU)

(74) Representative: Hart, Deborah Mary et al
Kilburn & Strode 20 Red Lion Street
London WC1R 4PJ
London WC1R 4PJ (GB)

   


(54) Nucleic acids and proteins from streptococcus pneumoniae


(57) Novel proteins from Streptococcus pneumoniae are described, together with nucleic acid sequences encoding them. Their use in vaccines and in screening methods is also described.







Search report